A new partnership between researchers at Dana-Farber Cancer Institute and University College London (UCL) may prove decisive in the quest to develop the.
Ovarian cancer researchers disappointed after trial finds regular screenings fail to reduce deaths
A decades-long study on ovarian cancer has found that annual screening for the cancer did not ultimately reduce the number of deaths from the disease, says British researcher Usha Menon.
Social Sharing
CBC Radio ·
Posted: May 13, 2021 5:25 PM ET | Last Updated: May 13
A study that offered annual screening to more than 200,000 women did not find a reduction in ovarian cancer deaths. (CBC)
Ovarian Cancer Screening Trial Still Sees No Death Reduction medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
Study: Ovarian Cancer Screening Does Not Cut Deaths By Pam Harrison
May 18, 2021 Results from a huge British trial that involved more than 200,000 women show that annual screening for ovarian cancer did not reduce the death toll from this aggressive cancer. We are disappointed, as this is not the outcome we and everyone involved in the trial had hoped and worked for over so many years, said Usha Menon, MD, of the Institute of Clinical Trials and Methodology in London, and the study’s lead investigator.
The trial is the first “to show that screening can definitely detect ovarian cancer earlier. However, this very large, rigorous trial shows clearly that screening using either of the approaches we tested did not save lives, she said in a statement.
Early detection of ovarian cancer does not translate into saving lives news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.